The present disclosure describes bis-modified bicyclic nucleosides and oligomeric compounds that can be prepared comprising at least one of these bis-modified bicyclic nucleosides. More particularly, the bis-modified bicyclic nucleosides have at least one substituent group at the 5'-methylene and on the bridge methylene and can be chiral. These bis-modified bicyclic nucleosides are expected to be useful for enhancing one or more property of oligomeric compounds including for example enhancing nuclease resistance.
Claims What is claimed is: 1. A bicyclic nucleoside having Formula I: ##STR00039## wherein: Bx is a heterocyclic base moiety; one of T.sub.1 and T.sub.2 is H or a hydroxyl protecting group and the other of T.sub.1 and T.sub.2 is H, a hydroxyl protecting group or a reactive phosphorus group; one of Z.sub.1 and Z.sub.2 is H, C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl or substituted C.sub.2-C.sub.6 alkynyl and the other one of Z.sub.1 and Z.sub.2 is C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl or substituted C.sub.2-C.sub.6 alkynyl; one of Q.sub.1 and Q.sub.2 is H, C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl, substituted C.sub.2-C.sub.6 alkynyl, thiol or substituted thiol and the other one of Q.sub.1 and Q.sub.2 is C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl, substituted C.sub.2-C.sub.6 alkynyl, thiol or substituted thiol; or Q.sub.1 and Q.sub.2 together are methylene (.dbd.CH.sub.2); each substituted group is mono or poly substituted with substituent groups independently selected from halogen, OJ.sub.1, SJ.sub.1, NJ.sub.1J.sub.2, N.sub.3, COOJ.sub.1, CN, O--C(.dbd.O)NJ.sub.1J.sub.2, N(H)C(.dbd.NH)NJ.sub.1J.sub.2, N(H)C(.dbd.O)N(H)J.sub.2 or N(H)C(.dbd.S)N(H)J.sub.2; and each J.sub.1 and J.sub.2 is, independently, H, C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl, C.sub.1-C.sub.6 aminoalkyl or a protecting group. 2. The bicyclic nucleoside of claim 1 wherein Z.sub.1 and Z.sub.2 are each, independently, C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl or substituted C.sub.2-C.sub.6 alkynyl. 3. The bicyclic nucleoside of claim 2 wherein Z.sub.1 and Z.sub.2 are each CH.sub.3. 4. The bicyclic nucleoside of claim 1 wherein one of Z.sub.1 and Z.sub.2 is H. 5. The bicyclic nucleoside of claim 4 wherein the other one of Z.sub.1 and Z.sub.2 is substituted C.sub.1-C.sub.6 alkyl. 6. The bicyclic nucleoside of claim 5 wherein the other one of Z.sub.1 and Z.sub.2 is CH.sub.2F, CHF.sub.2 or CF.sub.3. 7. The bicyclic nucleoside of claim 4 wherein the other one of Z.sub.1 and Z.sub.2 is C.sub.1-C.sub.6 alkyl. 8. The bicyclic nucleoside of claim 7 wherein the other one of Z.sub.1 and Z.sub.2 is CH.sub.3. 9. The bicyclic nucleoside of claim 1 wherein Q.sub.1 and Q.sub.2 are each, independently, C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl, substituted C.sub.2-C.sub.6 alkynyl, thiol or substituted thiol. 10. The bicyclic nucleoside of claim 9 wherein Q.sub.1 and Q.sub.2 are each CH.sub.3. 11. The bicyclic nucleoside of claim 1 wherein one of Q.sub.1 and Q.sub.2 is H. 12. The bicyclic nucleoside of claim 11 wherein the other one of Q.sub.1 and Q.sub.2 is substituted C.sub.1-C.sub.6 alkyl. 13. The bicyclic nucleoside of claim 12 wherein the other one of Q.sub.1 and Q.sub.2 is CH.sub.2F, CHF.sub.2 or CF.sub.3. 14. The bicyclic nucleoside of claim 11 wherein the other one of Q.sub.1 and Q.sub.2 is C.sub.1-C.sub.6 alkyl. 15. The bicyclic nucleoside of claim 14 wherein the other one of Q.sub.1 and Q.sub.2 is CH.sub.3. 16. The bicyclic nucleoside of claim 1 wherein Q.sub.1 and Q.sub.2 together are methylene (.dbd.CH.sub.2). 17. The bicyclic nucleoside of claim 16 wherein one of Z.sub.1 and Z.sub.2 is CH.sub.3 and the other one of Z.sub.1 and Z.sub.2 is H. 18. The bicyclic nucleoside of claim 1 having Formula II: ##STR00040## wherein: Bx is a heterocyclic base moiety; one of T.sub.1 and T.sub.2 is H or a hydroxyl protecting group and the other of T.sub.1 and T.sub.2 is H, a hydroxyl protecting group or a reactive phosphorus group; one of Z.sub.1 and Z.sub.2 is H, C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl or substituted C.sub.2-C.sub.6 alkynyl and the other one of Z.sub.1 and Z.sub.2 is C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl or substituted C.sub.2-C.sub.6 alkynyl; one of Q.sub.1 and Q.sub.2 is H, C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl, substituted C.sub.2-C.sub.6 alkynyl, thiol or substituted thiol and the other one of Q.sub.1 and Q.sub.2 is C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl, substituted C.sub.2-C.sub.6 alkynyl, thiol or substituted thiol; or Q.sub.1 and Q.sub.2 together are methylene (.dbd.CH.sub.2); each substituted group is mono or poly substituted with substituent groups independently selected from halogen, OJ.sub.1, SJ.sub.1, NJ.sub.1J.sub.2, N.sub.3, COOJ.sub.1, CN, O--C(.dbd.O)NJ.sub.1J.sub.2, N(H)C(.dbd.NH)NJ.sub.1J.sub.2, N(H)C(.dbd.O)N(H)J.sub.2 or N(H)C(.dbd.S)N(H)J.sub.2; and each J.sub.1 and J.sub.2 is, independently, H, C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl, C.sub.1-C.sub.6 aminoalkyl or a protecting group. 19. The bicyclic nucleoside of claim 18 wherein Z.sub.2 and Q.sub.2 are each H. 20. The bicyclic nucleoside of claim 19 wherein Z.sub.1 and Q.sub.1 are each CH.sub.3. 21. The bicyclic nucleoside of claim 18 wherein Z.sub.2 and Q.sub.1 are each H. 22. The bicyclic nucleoside of claim 21 wherein Z.sub.1 and Q.sub.2 are each CH.sub.3. 23. The bicyclic nucleoside of claim 18 wherein Z.sub.1 and Q.sub.2 are each H. 24. The bicyclic nucleoside of claim 23 wherein Z.sub.2 and Q.sub.1 are each CH.sub.3. 25. The bicyclic nucleoside of claim 18 wherein Z.sub.1 and Q.sub.1 are each H. 26. The bicyclic nucleoside of claim 25 wherein Z.sub.2 and Q.sub.2 are each CH.sub.3. 27. The bicyclic nucleoside of claim 1 wherein Bx is uracil, 5-thiazolo-uracil, 2-thio-uracil, 5-propynyl-uracil, thymine, 2'-thio-thymine, cytosine, 5-methylcytosine, 5-thiazolo-cytosine, 5-propynyl-cytosine, adenine, guanine, 2,6-diaminopurine, 1H-pyrimido[5,4-b][1,4-benzoxazin-2(3H)-one), 1H-pyrimido[5,4-b][1,4]benzothiazin-2(3H)-one, 9-(2-aminoethoxy)-H-pyrimido[5,4-b][1,4]benzoxazin-2(3H)-one, 2H-pyrimido[4,5-b]indol-2-one or H-pyrido[3',2':4,5]pyrrolo[2,3-d]pyrimidin-2-one. 28. The bicyclic nucleoside of claim 27 wherein Bx is uracil, thymine, cytosine, 5-methyl-cytosine, 2,6-diaminopurine, adenine or guanine. 29. The bicyclic nucleoside of claim 1 wherein T.sub.1 is selected from acetyl, benzyl, t-butyl-dimethylsilyl, t-butyldiphenylsilyl and dimethoxytrityl. 30. The bicyclic nucleoside of claim 1 wherein T.sub.1 is 4,4'-dimethoxytrityl. 31. The bicyclic nucleoside of claim 1 wherein T.sub.2 is a reactive phosphorus group selected from diisopropylcyanoethoxy phosphoramidite or H-phosphonate. 32. The bicyclic nucleoside claim 31 wherein T.sub.1 is 4,4'-dimethoxytrityl and T.sub.2 is diisopropyl-cyanoethoxy phosphoramidite. 33. An oligomeric compound having at least one bicyclic nucleoside of Formula III: ##STR00041## wherein independently for each bicyclic nucleoside having Formula III: Bx is a heterocyclic base moiety; T.sub.3 and T.sub.4 are each, independently, an internucleoside linking group linking the bicyclic nucleoside of Formula III to the oligomeric compound or one of T.sub.3 and T.sub.4 is an internucleoside linking group linking the bicyclic nucleoside of Formula III to the oligomeric compound and the other of T.sub.3 and T.sub.4 is H, a hydroxyl protecting group, a linked conjugate group or a 5' or 3'-terminal group; one of Z.sub.1 and Z.sub.2 is H, C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl or substituted C.sub.2-C.sub.6 alkynyl and the other one of Z.sub.1 and Z.sub.2 is C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl or substituted C.sub.2-C.sub.6 alkynyl; one of Q.sub.1 and Q.sub.2 is H, C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl, substituted C.sub.2-C.sub.6 alkynyl, thiol or substituted thiol and the other one of Q.sub.1 and Q.sub.2 is C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl, substituted C.sub.2-C.sub.6 alkynyl, thiol or substituted thiol; or Q.sub.1 and Q.sub.2 together are methylene (.dbd.CH.sub.2); each substituted group is mono or poly substituted with substituent groups independently selected from halogen, OJ.sub.1, SJ.sub.1, NJ.sub.1J.sub.2, N.sub.3, COOJ.sub.1, CN, O--C(.dbd.O)NJ.sub.1J.sub.2, N(H)C(.dbd.NH)NJ.sub.1J.sub.2, N(H)C(.dbd.O)N(H)J.sub.2 or N(H)C(.dbd.S)N(H)J.sub.2; and each J.sub.1 and J.sub.2 is, independently, H, C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl, C.sub.1-C.sub.6 aminoalkyl or a protecting group. 34. The oligomeric compound of claim 33 wherein Z.sub.1 and Z.sub.2 are each, independently, C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl or substituted C.sub.2-C.sub.6 alkynyl for essentially each bicyclic nucleoside having Formula III. 35. The oligomeric compound of claim 34 wherein Z.sub.1 and Z.sub.2 are each CH.sub.3 for essentially each bicyclic nucleoside having Formula III. 36. The oligomeric compound of claim 33 wherein one of Z.sub.1 and Z.sub.2 is H for essentially each bicyclic nucleoside having Formula III. 37. The oligomeric compound of claim 36 wherein the other one of Z.sub.1 and Z.sub.2 is substituted C.sub.1-C.sub.6 alkyl for essentially each bicyclic nucleoside having Formula III. 38. The oligomeric compound of claim 37 wherein the other one of Z.sub.1 and Z.sub.2 is CH.sub.2F, CHF.sub.2 or CF.sub.3 for essentially each bicyclic nucleoside having Formula III. 39. The oligomeric compound of claim 36 wherein the other one of Z.sub.1 and Z.sub.2 is C.sub.1-C.sub.6 alkyl for essentially each bicyclic nucleoside having Formula III. 40. The oligomeric compound of claim 39 wherein the other one of Z.sub.1 and Z.sub.2 is CH.sub.3 for essentially each bicyclic nucleoside having Formula III. 41. The oligomeric compound of claim 33 wherein Q.sub.1 and Q.sub.2 are each, independently, C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl, substituted C.sub.2-C.sub.6 alkynyl, thiol or substituted thiol for essentially each bicyclic nucleoside having Formula III. 42. The oligomeric compound of claim 41 wherein Q.sub.1 and Q.sub.2 are each CH.sub.3 for essentially each bicyclic nucleoside having Formula III. 43. The oligomeric compound of claim 33 wherein one of Q.sub.1 and Q.sub.2 is H for essentially each bicyclic nucleoside having Formula III. 44. The oligomeric compound of claim 43 wherein the other one of Q.sub.1 and Q.sub.2 is substituted C.sub.1-C.sub.6 alkyl for essentially each bicyclic nucleoside having Formula III. 45. The oligomeric compound of claim 44 wherein the other one of Q.sub.1 and Q.sub.2 is CH.sub.2F, CHF.sub.2 or CF.sub.3 for essentially each bicyclic nucleoside having Formula III. 46. The oligomeric compound of claim 43 wherein the other one of Q.sub.1 and Q.sub.2 is C.sub.1-C.sub.6 alkyl for essentially each bicyclic nucleoside having Formula III. 47. The oligomeric compound of claim 46 wherein the other one of Q.sub.1 and Q.sub.2 is CH.sub.3 for essentially each bicyclic nucleoside having Formula III. 48. The oligomeric compound of claim 33 wherein Q.sub.1 and Q.sub.2 together are methylene (.dbd.CH.sub.2) for essentially each bicyclic nucleoside having Formula III. 49. The oligomeric compound of claim 48 wherein one of Z.sub.1 and Z.sub.2 is CH.sub.3 and the other one of Z.sub.1 and Z.sub.2 is H for essentially each bicyclic nucleoside having Formula III. 50. The oligomeric compound of claim 33 having Formula IV: ##STR00042## wherein independently for each bicyclic nucleoside having Formula IV: Bx is a heterocyclic base moiety; T.sub.3 and T.sub.4 are each, independently, an internucleoside linking group linking the bicyclic nucleoside of Formula IV to the oligomeric compound or one of T.sub.3 and T.sub.4 is an internucleoside linking group linking the bicyclic nucleoside of Formula IV to the oligomeric compound and the other of T.sub.3 and T.sub.4 is H, a hydroxyl protecting group, a linked conjugate group or a 5' or 3'-terminal group; one of Z.sub.1 and Z.sub.2 is H, C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl or substituted C.sub.2-C.sub.6 alkynyl and the other one of Z.sub.1 and Z.sub.2 is C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl or substituted C.sub.2-C.sub.6 alkynyl; one of Q.sub.1 and Q.sub.2 is H, C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl, substituted C.sub.2-C.sub.6 alkynyl, thiol or substituted thiol and the other one of Q.sub.1 and Q.sub.2 is C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl, substituted C.sub.2-C.sub.6 alkynyl, thiol or substituted thiol; or Q.sub.1 and Q.sub.2 together are methylene (.dbd.CH.sub.2); each substituted group is mono or poly substituted with substituent groups independently selected from halogen, OJ.sub.1, SJ.sub.1, NJ.sub.1J.sub.2, N.sub.3, COOJ.sub.1, CN, O--C(.dbd.O)NJ.sub.1J.sub.2, N(H)C(.dbd.NH)NJ.sub.1J.sub.2, N(H)C(.dbd.O)N(H)J.sub.2 or N(H)C(.dbd.S)N(H)J.sub.2; and each J.sub.1 and J.sub.2 is, independently, H, C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl, C.sub.1-C.sub.6 aminoalkyl or a protecting group. 51. The oligomeric compound of claim 50 wherein Z.sub.2 and Q.sub.2 are each H for essentially each bicyclic nucleoside having Formula IV. 52. The oligomeric compound of claim 51 wherein Z.sub.1 and Q.sub.1 are each CH.sub.3 for essentially each bicyclic nucleoside having Formula IV. 53. The oligomeric compound of claim 50 wherein Z.sub.2 and Q.sub.1 are each H for essentially each bicyclic nucleoside having Formula IV. 54. The oligomeric compound of claim 53 wherein Z.sub.1 and Q.sub.2 are each CH.sub.3 for essentially each bicyclic nucleoside having Formula IV. 55. The oligomeric compound of claim 50 wherein Z.sub.1 and Q.sub.2 are each H for essentially each bicyclic nucleoside having Formula IV. 56. The oligomeric compound of claim 55 wherein Z.sub.2 and Q.sub.1 are each CH.sub.3 for essentially each bicyclic nucleoside having Formula IV. 57. The oligomeric compound of claim 50 wherein Z.sub.1 and Q.sub.1 are each H for essentially each bicyclic nucleoside having Formula IV. 58. The oligomeric compound of claim 57 wherein Z.sub.2 and Q.sub.2 are each CH.sub.3 for essentially each bicyclic nucleoside having Formula IV. 59. The oligomeric compound of claim 33 wherein Bx is uracil, 5-thiazolo-uracil, 2-thio-uracil, 5-propynyl-uracil, thymine, 2'-thio-thymine, cytosine, 5-methylcytosine, 5-thiazolo-cytosine, 5-propynyl-cytosine, adenine, guanine, 2,6-diaminopurine, 1H-pyrimido[5,4-b][1,4-benzoxazin-2(3H)-one),1H-pyrimido[5,4-b][1,4]benzo- thiazin-2(3H)-one, 9-(2-aminoethoxy)-H-pyrimido[5,4-b][1,4]benzoxazin-2(3H)-one, 2H-pyrimido[4,5-b]indol-2-one or H-pyrido[3',2':4,5]pyrrolo[2,3-d]pyrimidin-2-one for essentially each bicyclic nucleoside having Formula IV. 60. The oligomeric compound of claim 59 wherein Bx is uracil, thymine, cytosine, 5-methyl-cytosine, 2,6-diaminopurine, adenine or guanine for essentially each bicyclic nucleoside having Formula IV. 61. The oligomeric compound of claim 33 wherein each internucleoside linking group is, independently, a phosphodiester or phosphorothioate. 62. The oligomeric compound of claim 33 wherein each internucleoside linking group is a phosphorothioate. 63. The oligomeric compound of claim 33 comprising at least two regions wherein each region independently comprises at least two contiguous bicyclic nucleosides having Formula III and wherein the two regions are separated by a plurality of monomeric subunits. 64. The oligomeric compound of claim 63 wherein said plurality of monomeric subunits comprise a plurality of .beta.-D-2'-deoxyribofuranosyl nucleosides. 65. The oligomeric compound of claim 33 comprising from about 8 to about 40 monomeric subunits. 66. The oligomeric compound of claim 33 comprising from about 8 to about 20 monomeric subunits. 67. The oligomeric compound of claim 33 comprising from about 10 to about 16 monomeric subunits. 68. The oligomeric compound of claim 33 comprising from about 10 to about 14 monomeric subunits. 